Erik Hallqvist Osterman
Doktorand vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerprecisionsmedicin; Forskargrupp Tobias Sjöblom
- E-post:
- erik.osterman@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 37 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 Uppsala
Affilierad Forskare vid Centrum för klinisk forskning, Gävleborg
- Besöksadress:
- Gävle sjukhus -157-
Ingång 9 A
801 88 Gävle - Postadress:
- Region Gävleborg
801 88 GÄVLE
Ladda ned kontaktuppgifter för Erik Hallqvist Osterman vid Centrum för klinisk forskning, Gävleborg
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Forskar på risken för återfall efter radikal koloncancerkirurgi och behovet av cytostatika. Arbetar kliniskt som ST-läkare på kirurgkliniken, Akademiska sjukhuset där fokus ligger i på akutkirurgi.
Forskar även på akut kolecystit och socioekonomiska skillnader i behandling av kolorektalcancer.
Publikationer
Urval av publikationer
- Colon Cancer, Prognosis After Surgery (2021)
- Accurate population-based model for individual prediction of colon cancer recurrence (2021)
- Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer (2021)
- Recurrence Risk after Radical Colorectal Cancer Surgery (2020)
- Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology (2018)
Senaste publikationer
- Surgery for acute cholecystitis in severely comorbid patients (2022)
- Colon Cancer, Prognosis After Surgery (2021)
- Accurate population-based model for individual prediction of colon cancer recurrence (2021)
- Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer (2021)
- Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients (2020)
Alla publikationer
Artiklar
- Surgery for acute cholecystitis in severely comorbid patients (2022)
- Accurate population-based model for individual prediction of colon cancer recurrence (2021)
- Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer (2021)
- Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients (2020)
- ASO Author Reflections (2020)
- Recurrence Risk after Radical Colorectal Cancer Surgery (2020)
- Beyond the NCCN Risk Factors in Colon Cancer (2020)
- Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer (2019)
- Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology (2018)
- Prognostic whole-genome and transcriptome signatures in colorectal cancers